Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Neumann

Showing results (231-240 of 301) with videos related to

Pageof 31
Sort By:
JAMA|May 20, 2020
Coverage for Biosimilars vs Reference Products Among US Commercial Health PlansJames D Chambers, Rachel C Lai, Nikoletta M Margaretos, et al.
Applied Health Economics and Health Policy|November 11, 2016
Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product ApprovalJames D Chambers, Teja Thorat, Colby L Wilkinson, et al.
International Journal of Technology Assessment in Health Care|January 12, 2010
Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?, Peter J Neumann, Michael F Drummond, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Principles for planning and conducting comparative effectiveness researchBryan R Luce, Michael F Drummond, Robert W Dubois, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthPei-Jung Lin, Abigail G Riley, Patricia G Synnott, et al.
The Lancet. Infectious Diseases|May 28, 2005
A synthesis of cost-utility analysis literature in infectious diseasePatricia W Stone, Bruce R Schackman, Christopher P Neukermans, et al.
Pharmacoeconomics|June 16, 2011
A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policyJoseph Menzin, Lisa M Lines, Daniel E Weiner, et al.
BMJ (Clinical Research Ed.)|February 24, 2006
Bias in published cost effectiveness studies: systematic reviewChaim M Bell, David R Urbach, Joel G Ray, et al.
Pharmacoeconomics|March 24, 2019
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease InterventionsPei-Jung Lin, Brittany D'Cruz, Ashley A Leech, et al.
International Journal of Technology Assessment in Health Care|July 8, 2008
Key principles for the improved conduct of health technology assessments for resource allocation decisionsMichael F Drummond, J Sanford Schwartz, Bengt Jönsson, et al.
Pageof 31

Showing results (231-240 of 301) with videos related to

Sort By:
Pageof 31
JAMA|May 20, 2020
Coverage for Biosimilars vs Reference Products Among US Commercial Health PlansJames D Chambers, Rachel C Lai, Nikoletta M Margaretos, et al.
Applied Health Economics and Health Policy|November 11, 2016
Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product ApprovalJames D Chambers, Teja Thorat, Colby L Wilkinson, et al.
International Journal of Technology Assessment in Health Care|January 12, 2010
Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?, Peter J Neumann, Michael F Drummond, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Principles for planning and conducting comparative effectiveness researchBryan R Luce, Michael F Drummond, Robert W Dubois, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthPei-Jung Lin, Abigail G Riley, Patricia G Synnott, et al.
The Lancet. Infectious Diseases|May 28, 2005
A synthesis of cost-utility analysis literature in infectious diseasePatricia W Stone, Bruce R Schackman, Christopher P Neukermans, et al.
Pharmacoeconomics|June 16, 2011
A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policyJoseph Menzin, Lisa M Lines, Daniel E Weiner, et al.
BMJ (Clinical Research Ed.)|February 24, 2006
Bias in published cost effectiveness studies: systematic reviewChaim M Bell, David R Urbach, Joel G Ray, et al.
Pharmacoeconomics|March 24, 2019
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease InterventionsPei-Jung Lin, Brittany D'Cruz, Ashley A Leech, et al.
International Journal of Technology Assessment in Health Care|July 8, 2008
Key principles for the improved conduct of health technology assessments for resource allocation decisionsMichael F Drummond, J Sanford Schwartz, Bengt Jönsson, et al.
Pageof 31